示卓安超声造影在肝脏疾病中的研究进展

张 维桢1, 李 鹏1, 张灵 强*1, 陈 倩2
1、青海大学附属医院肝胆胰外科
2、青海大学附属医院麻醉科

摘要


随着超声造影技术的发展，Sonazoid（示卓安）作为新一代超声微泡造影剂崭露头角。其凭借Kupffer相的独特机制，使肝内显影时长较传统造影剂延长，能够捕捉肝脏病变的细微血流变化与组织特征，为临床诊断，治疗，随访肝脏疾病提供了更多有价值的信息，Sonazoid为肝脏疾病全周期管理提供了关键影像依据。本文将围绕其临床应用现状与前沿进展展开系统综述。

关键词


造影剂；肝脏；超声造影检查

全文:

PDF


参考


[1]BARR R G ， HUANG P ， LUO Y ， et al. Contrast-enhanced ultrasound imaging of the liver：A review of the clinical evidence for SonoVue and Sonazoid[J]. Abdom Radiol（NY），2020，45（11）：3779-3788 .

[2]LI P ， HOPPMANN S ， DU P ， et al. Pharmacokinetics of perfluorobutane after intra-venous bolus injection of Sonazoid in healthy Chinese volunteers[J]. Ultrasound Med Biol ，2017，43（5）：1031-1039 .

[3]KANG T W ，LEE M W ，SONG K D ，et al. Added value of contrast-enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance[J]. Korean J Radiol，2017， 18（1）：152-161.

[4]Barr RG, Huang PT, Luo Y, et al. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid[J]. Abdom Radiol (NY), 2020, 45(11): 3779-88.

[5]闻晶晶，沈海云，孔文韬.超声造影引导下经皮肝穿刺活检对肝脏局灶性病变的诊断价值[J].临床超声医学杂志，2022，24（4）：3135.

[6]Huang JX, Shi CG, Xu YF, et al. The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases[J]. Eur Radiol, 2022, 32(10): 6830-9.

[7]Wu W, Jing X, Xue GQ, et al. A multicenter randomized controlled study of contrast-enhanced US versus US-guided biopsy of focal liver lesions[J]. Radiology, 2022, 305(3): 721-8.

[8]SHI H，ONG Y T，GOGNA A，et al. Perfluorobutane contrast- enhanced ultrasonography：A new standard for ultrasonography - guided thermal ablation of sonographically occult liver tumours？[J]. Singapore Med J，2021，62（10）：546-553 .

[9]MUKUND A ， BANSAL A ， PATIDAR Y ， et al. Role of contrast-enhanced ultrasound with perfluorobutane in lesion detection ， guidance for microwave ablation ， and response assessment of hepatocellular carcinoma [J]. Abdom Radiol （NY），2022，47（10）：3459-3467 .

[10]刘德林，孔梓祥，梁妃，等.示卓安超声造影在小肝癌微波消融术中的应用价值[J].医学影像学杂志，2024，34（5）：105～106，110.

[11]JEONG W K . Diagnosis of hepatocellular carcinoma using Sonazoid：A comprehensive review[J]. J Liver Cancer，2023，23（2）：272-283 .

[12]Wang Z, Yao J, Jing X, et al. A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study. Abdom Radiol (NY), 2024, 49(10): 3427～3437.

[13]张雨，汤群锋，吴鸣宇，等.Sonazoid超声造影与普美显增强MRI诊断肝细胞肝癌的对比研究.临床超声医学杂志，2024，26（8）：630～635.

[14]WU Q，LIU Y，SUN D，et al. Protocol of Kupffer phase whole liver scan for metastases ：A single-center prospective study[J]. Front Med（Lausanne），2022，9：911807 .

[15]SUN L，YIN S，XING B，et al. Contrast-enhanced ultrasound with SonoVue and Sonazoid for the diagnosis of colorectal liver metastasis after chemotherapy[J]. J Ultrasound Med ，2023，42.

[16]TRANQUART F . Contrast-enhanced ultrasound with Sonazoid for the imaging and diagnosis of colorectal liver metastasis[J]. J Ultrasound Med，2023，42（6）：1371-1374 .

[17]邓旭.基于倾向性评分匹配的微波消融治疗肝泡型棘球蚴病的疗效分析[D].青海大学，2022.DOI：10.27740/d.cnki.gqhdx.2022.000261.

[18]Claudon M, Dietrich C, Choi B I, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS[J]. 2012.

[19]Barr, R. G., Huang, P., Luo, Y., Xie, X., Zheng, R., Yan, K., Jing, X., Luo, Y., Xu, H., Fei, X., & Lee, J. M. (2020). Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Abdominal radiology (New York), 45(11), 3779-3788.

[20]韩红，丁红，黄备建，毛丽娟，方超，王文平.Sonazoid及SonoVue超声造影下肝局灶性病变的灌注模式探讨及与增强MRI的比较研究[J].肿瘤影像学，2020，29（06）：559-564.DOI：10.19732/j.cnki.2096-6210.2020.06.007.

[21]王浩然，肖新广.CT肺血管造影联合双能量肺灌注成像对老年性肺栓塞治疗疗效的评估[J].中国临床医学影像杂志，2019，30（10）：685-689.

[22]贾小青，常晓悦，姚行艳，等.80例使用炫速双源CT肺动脉成像联合双能量肺灌注与使用单源多螺旋CT诊断肺血栓栓塞症的临床分析[J].影像研究与医学应用，2019，3（20）：24-26.

[23]VELÁZQUEZ M, MANEIRO N, LAREO A, et al. Selective segmental pulmonary angiography: anatomical, technical and safety aspects of a must-learn technique in times of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension [J/OL]. J Clin Med,2021, 10(15):3358.https://doi.org/10.3390/jcm10153358.

[24]潘婷，夏蕾，石容容，等.CT肺动脉造影结合血清学标志物在急性肺栓塞诊断中的应用[J].中国CT和MRI杂志，2023，21（4）：67-69.

[25]Squires JH, McCarville MB. Contrast- enhanced ultrasound in children: implementation and key diagnostic applications[J]. AJR Am J Roentgenol, 2021, 217(5): 1217-31.

[26]Shang YN, Xie XY, Luo Y, et al. Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463, 434 examinations at 24 centers[J]. Eur Radiol, 2023, 33(2): 988-95.

[27]Dietrich CF, Augustiniene R, Batko T, et al. European federation of societies for ultrasound in medicine andBiology (EFSUMB): an update on the pediatric CEUS registry onBehalf of the “EFSUMB pediatric CEUS registry working group”[J]. Ultraschall Med, 2021, 42(3): 270-7.

[28]Windrim R, Kingdom J, Jang HJ, et al. Contrast enhanced ultrasound (CEUS) in the prenatal evaluation of suspected invasive placenta percreta[J]. J D'obstetrique Gynecol Du Can, 2016, 38(10): 975-8.

[29]Xiong X, Yan P, Gao CY, et al. The value of contrast- enhanced ultrasound in the diagnosis of cesarean scar pregnancy[J]. Biomed Res Int, 2016, 2016: 4762785.

[30]Schwarze V, Marschner C, Negrão de Figueiredo G, et al. Singlecenter study: evaluating the diagnostic performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions[J]. Ultraschall Med, 2020, 41(1): 29-35.

[31]何蒙娜，姜玉新，吕珂.超声造影剂Sonazoid与SonoVue的物理特征及临床特点比较[J].中国医学影像技术，2015，31（2）：306-309.

[32]李加伍，凌文武，陈爽，等.肝脏病灶大小及肝细胞癌分化程度对超声造影肝脏影像报告与数据管理系统分类诊断的影响[J].中国医学影像技术，2022，38（9）：1356-1360.


Refbacks

  • 当前没有refback。